Study estimates 6-times-higher odds of COVID in households amid Omicron
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Two studies published today measure the vaccine effectiveness (VE) of COVID-19 vaccines against laboratory-confirmed Omicron variant and subvariants and symptomatic disease. Vaccines that target the newer variants performed well, but primary vaccines offered rapidly waning protection from SARS-CoV-2 infections in the post-Omicron era.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on